Beijing Tiantan Biological Products Corp Ltd - ESG Rating & Company Profile powered by AI
This webpage displays a free ESG analysis for Beijing Tiantan Biological Products Corp Ltd. This SDG score for Beijing Tiantan Biological Products Corp Ltd indicates the company's transparency towards the UN SDGs. If you are employed by Beijing Tiantan Biological Products Corp Ltd and you wish to use your ESG rating, please contact us.
Beijing Tiantan Biological Products Corp Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Beijing Tiantan Biological Products Corp Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Beijing Tiantan Biological Products Corp Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Beijing Tiantan Biological Products Corp Ltd disclose current and historical energy intensity?
Does Beijing Tiantan Biological Products Corp Ltd report the average age of the workforce?
Does Beijing Tiantan Biological Products Corp Ltd reference operational or capital allocation in relation to climate change?
Does Beijing Tiantan Biological Products Corp Ltd disclose its ethnicity pay gap?
Does Beijing Tiantan Biological Products Corp Ltd disclose cybersecurity risks?
Does Beijing Tiantan Biological Products Corp Ltd offer flexible work?
Does Beijing Tiantan Biological Products Corp Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Beijing Tiantan Biological Products Corp Ltd disclose the number of employees in R&D functions?
Does Beijing Tiantan Biological Products Corp Ltd conduct supply chain audits?
Does Beijing Tiantan Biological Products Corp Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Beijing Tiantan Biological Products Corp Ltd conduct 360 degree staff reviews?
Does Beijing Tiantan Biological Products Corp Ltd disclose the individual responsible for D&I?
Does Beijing Tiantan Biological Products Corp Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Beijing Tiantan Biological Products Corp Ltd disclose current and / or historical scope 2 emissions?
Does Beijing Tiantan Biological Products Corp Ltd disclose water use targets?
Does Beijing Tiantan Biological Products Corp Ltd have careers partnerships with academic institutions?
Did Beijing Tiantan Biological Products Corp Ltd have a product recall in the last two years?
Does Beijing Tiantan Biological Products Corp Ltd disclose incidents of discrimination?
Does Beijing Tiantan Biological Products Corp Ltd allow for Work Councils/Collective Agreements to be formed?
Has Beijing Tiantan Biological Products Corp Ltd issued a profit warning in the past 24 months?
Does Beijing Tiantan Biological Products Corp Ltd disclose parental leave metrics?
Does Beijing Tiantan Biological Products Corp Ltd disclose climate scenario or pathway analysis?
Does Beijing Tiantan Biological Products Corp Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Beijing Tiantan Biological Products Corp Ltd disclose the pay ratio of women to men?
Does Beijing Tiantan Biological Products Corp Ltd support suppliers with sustainability related research and development?
Does Beijing Tiantan Biological Products Corp Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Beijing Tiantan Biological Products Corp Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Beijing Tiantan Biological Products Corp Ltd involved in embryonic stem cell research?
Does Beijing Tiantan Biological Products Corp Ltd disclose GHG and Air Emissions intensity?
Does Beijing Tiantan Biological Products Corp Ltd disclose its waste policy?
Does Beijing Tiantan Biological Products Corp Ltd report according to TCFD requirements?
Does Beijing Tiantan Biological Products Corp Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Beijing Tiantan Biological Products Corp Ltd disclose energy use targets?
Does Beijing Tiantan Biological Products Corp Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Beijing Tiantan Biological Products Corp Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Beijing Tiantan Biological Products Corp Ltd
These potential risks are based on the size, segment and geographies of the company.
Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and consulting of blood products in China. Its products include blood intravenous injection immunoglobulin; blood human albumin; blood system intravenous injection; hepatitis B, freeze-dried hepatitis B, and tetanus human immunoglobulin; human immunoglobulin; and other blood products. The company was incorporated in 1998 and is headquartered in Beijing, China. Beijing Tiantan Biological Products Co., Ltd. operates as a subsidiary of China National Biotec Group Company Limited.